Journal
JOURNAL OF RHEUMATOLOGY
Volume 48, Issue 5, Pages 775-784Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.191370
Keywords
opioid use disorder; healthcare utilization; outcomes; time trends; rheumatic diseases; musculoskeletal diseases
Categories
Funding
- Division of Rheumatology at the University of Alabama at Birmingham
Ask authors/readers for more resources
In this study, opioid use disorder (OUD)-related hospitalizations and healthcare utilization outcomes were examined in people with 5 common musculoskeletal diseases, including gout, rheumatoid arthritis, fibromyalgia, osteoarthritis, and low back pain. The results showed an increase in OUD hospitalizations across all 5 diseases, with varying rates of increase. Additionally, differences in hospital charges and length of stay were observed among the different musculoskeletal diseases.
Objective. To examine opioid use disorder (OUD)-related hospitalizations and associated healthcare utilization outcomes in people with 5 common musculoskeletal diseases (MSD). Methods. We used the US National Inpatient Sample (NIS) data from 1998 to 2014 to examine the rates of OUD hospitalizations (per 100,000 NIS claims overall), time trends, and outcomes in 5 common rheumatic diseases: gout, rheumatoid arthritis (RA), fibromyalgia (FM), osteoarthritis (OA), and low back pain (LBP). Results. OUD hospitalization rate per 100,000 total NIS claims in 1998-2000 vs 2015-2016 (and increase) were as follows: gout, 0.05 vs 1.88 (36-fold); OA, 0.68 vs 10.22 (14-fold); FM, 0.53 vs 6.98 (12-fold); RA, 0.30 vs 3.16 (9.5-fold); and LBP, 1.17 vs 7.64 (5.5-fold). The median hospital charges and hospital stays for OUD hospitalizations were as follows: gout, $18,363 and 2.5 days; RA, $17,398 and 2.4 days; FM, $15,772 and 2.1 days; OA, $16,795 and 2.4 days; and LBP, $13,722 and 2.0 days. In-hospital mortality rates ranged from 0.9% for LBP and FM to 1.7% for gout with OUD hospitalizations. Compared to those without each MSD, age-, sex-, race-, and income-adjusted total hospital charges (inflation-adjusted) for OUD hospitalizations with each rheumatic disease were as follows: gout, $697 higher; OA, $4759 lower; FM, $2082 lower; RA, $1258 lower; and I.BP, $4944 lower. Conclusion. OUD hospitalizations increased in all 5 MSD studied, but the rate of increase differed. Awareness of these OUD hospitalization trends in 5 MSD among providers, policy makers, and patients is important. Development and implementation of interventions, policies, and practices to potentially reduce OUD-associated effects in people with rheumatic diseases is needed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available